¹³¹I-labeled polyethylenimine-entrapped gold nanoparticles for targeted tumor SPECT/CT imaging and radionuclide therapy

References

• Wicki A, Witzigmann D, Balasubramanian V, Huwyler J. Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. J Control Release. 2015;200:138–157. doi:10.1016/j.jconrel.2014.12.03025545217
   PubMed Web of Science ®Google Scholar
• Shi J, Kantoff PW, Wooster R, Farokhzad OC. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer. 2016;17(1):20–37. doi:10.1038/nrc.2016.10827834398
   PubMed Web of Science ®Google Scholar
• Bush NAO, Chang SM, Berger MS. Current and future strategies for treatment of glioma. Neurosurg Rev. 2017;40(1):1–14. doi:10.1007/s10143-016-0709-827085859
   PubMed Web of Science ®Google Scholar
• Chaichana KL, Jusue-Torres I, Lemos AM, et al. The butterfly effect on glioblastoma: is volumetric extent of resection more effective than biopsy for these tumors? J Neurooncol. 2014;120(3):625–634. doi:10.1007/s11060-014-1597-925193022
   PubMedGoogle Scholar
• Chaichana KL, Jusue-Torres I, Navarro-Ramirez R, et al. Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma. Neuro Oncol. 2014;16(1):113–122. doi:10.1093/neuonc/not13724285550
   PubMedGoogle Scholar
• Gallego O. Nonsurgical treatment of recurrent glioblastoma. Curr Oncol. 2015;22(4):9. doi:10.3747/co.22.2368
   Web of Science ®Google Scholar
• Chen X, Gambhir SS, Cheon J. Theranostic nanomedicine. Acc Chem Res. 2011;44(10):841. doi:10.1021/ar200231d22004477
   PubMedGoogle Scholar
• Signore A, Glaudemans AWJM. The molecular imaging approach to image infections and inflammation by nuclear medicine techniques. Ann Nucl Med. 2011;25(10):681–700. doi:10.1007/s12149-011-0521-z21837469
   PubMedGoogle Scholar
• Gomes CM, Abrunhosa AJ, Ramos P, Pauwels EKJ. Molecular imaging with SPECT as a tool for drug development. Adv Drug Deliv Rev. 2011;63(7):547–554. doi:10.1016/j.addr.2010.09.01520933557
   PubMedGoogle Scholar
• Ametamey SM, Honer M, Schubiger PA. Molecular imaging with PET. Chem Rev. 2008;108(5):1501–1516. doi:10.1021/cr078242618426240
   PubMed Web of Science ®Google Scholar
• Xing Y, Zhu J, Zhao L, et al. SPECT/CT imaging of chemotherapy-induced tumor apoptosis using 99mTc-labeled dendrimer-entrapped gold nanoparticles. Drug Deliv. 2018;25(1):1384–1393. doi:10.1080/10717544.2018.147496829869521
   PubMed Web of Science ®Google Scholar
• Rainone P, Riva B, Belloli S, et al. Development of 99mTc-radiolabeled nanosilica for targeted detection of HER2-positive breast cancer. Int J Nanomedicine. 2017;12:3447–3461. doi:10.2147/IJN.S12972028496321
   PubMedGoogle Scholar
• Chrastina A, Schnitzer JE. Iodine-125 radiolabeling of silver nanoparticles for in vivo SPECT imaging. Int J Nanomedicine. 2010;5:653–659. doi:10.2147/IJN.S1167720856841
   PubMed Web of Science ®Google Scholar
• Rangger C, Helbok A, Sosabowski J, et al. Tumor targeting and imaging with dual-peptide conjugated multifunctional liposomal nanoparticles. Int J Nanomedicine. 2013;8:4659–4671.24353415
   PubMed Web of Science ®Google Scholar
• Tsai C-C, Chang C-H, Chen L-C, et al. Biodistribution and pharmacokinetics of 188Re-liposomes and their comparative therapeutic efficacy with 5-fluorouracil in C26 colonic peritoneal carcinomatosis mice. Int J Nanomedicine. 2011;6:2607–2619.22114492
   PubMed Web of Science ®Google Scholar
• Zhao L, Zhu M, Li Y, et al. Radiolabeled dendrimers for nuclear medicine applications. Molecules. 2017;22(9):1350. doi:10.3390/molecules22091350
   PubMed Web of Science ®Google Scholar
• Zhao L, Zhu J, Cheng Y, et al. Chlorotoxin-conjugated multifunctional dendrimers labeled with radionuclide 131I for single photon emission computed tomography imaging and radiotherapy of gliomas. ACS Appl Mater Interfaces. 2015;7(35):19798–19808. doi:10.1021/acsami.5b0583626291070
   PubMedGoogle Scholar
• Kozempel J, Vlk M, Málková E, et al. Prospective carriers of 223Ra for targeted alpha particle therapy. J Radioanal Nucl Chem. 2015;304(1):443–447. doi:10.1007/s10967-014-3615-y
   Web of Science ®Google Scholar
• Toro-González M, Copping R, Mirzadeh S, Rojas JV. Multifunctional GdVO4: Eu core–shell nanoparticles containing 225Ac for targeted alpha therapy and molecular imaging. J Mater Chem B. 2018;6(47):7985–7997. doi:10.1039/C8TB02173B
   PubMed Web of Science ®Google Scholar
• Westrøm S, Malenge M, Jorstad IS, et al. Ra-224 labeling of calcium carbonate microparticles for internal α-therapy: preparation, stability, and biodistribution in mice. J Labelled Comp Radiopharm. 2018;61(6):472–486. doi:10.1002/jlcr.361029380410
   PubMedGoogle Scholar
• Mokhodoeva O, Vlk M, Málková E, et al. Study of 223Ra uptake mechanism by Fe3O4 nanoparticles: towards new prospective theranostic SPIONs. J Nanopart Res. 2016;18(10):301. doi:10.1007/s11051-016-3615-7
   Web of Science ®Google Scholar
• Chen L, Zhong X, Yi X, et al. Radionuclide 131I labeled reduced graphene oxide for nuclear imaging guided combined radio- and photothermal therapy of cancer. Biomaterials. 2015;66:21–28. doi:10.1016/j.biomaterials.2015.06.04326188609
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang Y, Yin L, et al. Synthesis and bioevaluation of iodine-131 directly labeled cyclic rgd-pegylated gold nanorods for tumor-targeted imaging. Contrast Media Mol Imaging. 2017;2017:6081724. doi:10.1155/2017/608172429434531
   PubMedGoogle Scholar
• Huang P, Zhang Y, Wang W, et al. Co-delivery of doxorubicin and 131I by thermosensitive micellar-hydrogel for enhanced in situ synergetic chemoradiotherapy. J Control Release. 2015;220:456–464. doi:10.1016/j.jconrel.2015.11.00726562684
   PubMed Web of Science ®Google Scholar
• Liu K, Zheng D, Zhao J, et al. pH-sensitive nanogels based on the electrostatic self-assembly of radionuclide 131I labeled albumin and carboxymethyl cellulose for synergistic combined chemo-radioisotope therapy of cancer. J Mater Chem B. 2018;6(29):4738–4746. doi:10.1039/C8TB01295D
   PubMed Web of Science ®Google Scholar
• Zhong X, Yang K, Dong Z, et al. Polydopamine as a biocompatible multifunctional nanocarrier for combined radioisotope therapy and chemotherapy of cancer. Adv Funct Mater. 2015;25(47):7327–7336. doi:10.1002/adfm.201503587
   Web of Science ®Google Scholar
• Li Z, Wang B, Zhang Z, et al. Radionuclide imaging-guided chemo-radioisotope synergistic therapy using a 131I-labeled polydopamine multifunctional nanocarrier. Mol Ther. 2018;26(5):1385–1393. doi:10.1016/j.ymthe.2018.02.01929567310
   PubMedGoogle Scholar
• Qiao W, Zhao L, Wu S, et al. SPECT imaging and radionuclide therapy of glioma using 131I labeled Buthus martensii Karsch chlorotoxin. J Neurooncol. 2017;133(2):287–295. doi:10.1007/s11060-017-2456-228488065
   PubMed Web of Science ®Google Scholar
• Cheng Y, Zhu J, Zhao L, et al. 131I-labeled multifunctional dendrimers modified with BmK CT for targeted SPECT imaging and radiotherapy of gliomas. Nanomedicine (Lond). 2016;11(10):1253–1266. doi:10.2217/nnm-2016-000126940668
   PubMedGoogle Scholar
• Mamelak AN, Rosenfeld S, Bucholz R, et al. Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma. J Clin Oncol. 2006;24(22):3644–3650. doi:10.1200/JCO.2005.05.456916877732
   PubMed Web of Science ®Google Scholar
• Cohen-Inbar O, Zaaroor M. Glioblastoma multiforme targeted therapy: the Chlorotoxin story. J Clin Neurosci. 2016;33:52–58. doi:10.1016/j.jocn.2016.04.01227452128
   PubMed Web of Science ®Google Scholar
• Krolicki L, Bruchertseifer F, Kunikowska J, et al. Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with 213Bi-substance P analogue. Eur J Nucl Med Mol Imaging. 2018;45(9):1636–1644. doi:10.1007/s00259-018-4015-229713762
   PubMedGoogle Scholar
• Hallouard F, Anton N, Choquet P, Constantinesco A, Vandamme T. Iodinated blood pool contrast media for preclinical X-ray imaging applications – a review. Biomaterials. 2010;31(24):6249–6268. doi:10.1016/j.biomaterials.2010.04.06620510444
   PubMedGoogle Scholar
• Qin J, Peng C, Zhao B, et al. Noninvasive detection of macrophages in atherosclerotic lesions by computed tomography enhanced with PEGylated gold nanoparticles. Int J Nanomedicine. 2014;9:5575–5590. doi:10.2147/IJN.S7281925506213
   PubMed Web of Science ®Google Scholar
• Day ES, Bickford LR, Slater JH, Riggall NS, Drezek RA, West JL. Antibody-conjugated gold-gold sulfide nanoparticles as multifunctional agents for imaging and therapy of breast cancer. Int J Nanomedicine. 2010;5:445–454.20957166
   PubMed Web of Science ®Google Scholar
• Guo J, Rahme K, He Y, Li L-L, Holmes JD, O’Driscoll CM. Gold nanoparticles enlighten the future of cancer theranostics. Int J Nanomedicine. 2017;12:6131–6152. doi:10.2147/IJN.S14077228883725
   PubMed Web of Science ®Google Scholar
• Popovtzer R, Agrawal A, Kotov NA, et al. Targeted gold nanoparticles enable molecular CT imaging of cancer. Nano Lett. 2008;8(12):4593–4596.19367807
   PubMed Web of Science ®Google Scholar
• Zhou B, Zheng L, Peng C, et al. Synthesis and characterization of pegylated polyethylenimine-entrapped gold nanoparticles for blood pool and tumor CT imaging. ACS Appl Mater Interfaces. 2014;6(19):17190–17199. doi:10.1021/am505006z25208617
   PubMedGoogle Scholar
• Zhu J, Sun W, Zhang J, et al. Facile formation of gold-nanoparticle-loaded γ-polyglutamic acid nanogels for tumor computed tomography imaging. Bioconjug Chem. 2017;28(11):2692–2697. doi:10.1021/acs.bioconjchem.7b0057129083866
   PubMedGoogle Scholar
• Muddineti OS, Ghosh B, Biswas S. Current trends in using polymer coated gold nanoparticles for cancer therapy. Int J Pharm. 2015;484(1):252–267. doi:10.1016/j.ijpharm.2015.02.03825701627
   PubMedGoogle Scholar
• Zhou B, Zhao L, Shen M, Zhao J, Shi X. A multifunctional polyethylenimine-based nanoplatform for targeted anticancer drug delivery to tumors. In Vivo J Mater Chem B. 2017;5(8):1542–1550. doi:10.1039/C6TB02620F
   PubMed Web of Science ®Google Scholar
• Zhao M-D, Cheng J-L, Yan J-J, et al. Hyaluronic acid reagent functional chitosan-PEI conjugate with AQP2-siRNA suppressed endometriotic lesion formation. Int J Nanomedicine. 2016;11:1323–1336. doi:10.2147/IJN.S9969227099493
   PubMed Web of Science ®Google Scholar
• Li J-M, Zhang W, Su H, et al. Reversal of multidrug resistance in MCF-7/Adr cells by codelivery of doxorubicin and BCL2 siRNA using a folic acid-conjugated polyethylenimine hydroxypropyl-β-cyclodextrin nanocarrier. Int J Nanomedicine. 2015;10:3147–3162. doi:10.2147/IJN.S6714625960653
   PubMed Web of Science ®Google Scholar
• Zhuang Y, Zhao L, Zheng L, et al. Laponite-polyethylenimine based theranostic nanoplatform for tumor-targeting CT imaging and chemotherapy. ACS Biomater Sci Eng. 2017;3(3):431–442. doi:10.1021/acsbiomaterials.6b00528
   PubMed Web of Science ®Google Scholar
• Zhou B, Wang R, Chen F, et al. 99mTc-labeled RGD-polyethylenimine conjugates with entrapped gold nanoparticles in the cavities for dual-mode SPECT/CT imaging of hepatic carcinoma. ACS Appl Mater Interfaces. 2018;10(7):6146–6154. doi:10.1021/acsami.7b1710729380596
   PubMedGoogle Scholar
• Zhao L, Wen S, Zhu M, et al. 99mTc-labelled multifunctional polyethylenimine-entrapped gold nanoparticles for dual mode SPECT and CT imaging. Artif Cells Nanomed Biotechnol. 2018;46(sup1):488–498. doi:10.1080/21691401.2018.1430696
   PubMed Web of Science ®Google Scholar